Todd P. Branning

Todd P. Branning is a declared insider at 2 companies (finance chief); the most frequent names are Ohr Pharmaceutical Inc and Amneal Pharmaceuticals, Inc. Over a trading history stretching from 22 January 2020 to 16 March 2023, the count stands at 6 filings.

On the market, this insider has only ever bought: 3 purchases, €47k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants and 1 option exercise.

A typical purchase (the median) is worth €16k. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 17 March 2023 with a share grant in Ohr Pharmaceutical Inc. The last insider purchase was made public on 21 March 2022, 1,678 days ago. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.